Style | Citing Format |
---|---|
MLA | Khorramirouz R, et al.. "Evaluating the Efficacy of Tissue-Engineered Human Amniotic Membrane in the Treatment of Myocardial Infarction." Regenerative Medicine, vol. 14, no. 2, 2019, pp. 113-126. |
APA | Khorramirouz R, Kameli SM, Fendereski K, Daryabari SS, Kajbafzadeh AM (2019). Evaluating the Efficacy of Tissue-Engineered Human Amniotic Membrane in the Treatment of Myocardial Infarction. Regenerative Medicine, 14(2), 113-126. |
Chicago | Khorramirouz R, Kameli SM, Fendereski K, Daryabari SS, Kajbafzadeh AM. "Evaluating the Efficacy of Tissue-Engineered Human Amniotic Membrane in the Treatment of Myocardial Infarction." Regenerative Medicine 14, no. 2 (2019): 113-126. |
Harvard | Khorramirouz R et al. (2019) 'Evaluating the Efficacy of Tissue-Engineered Human Amniotic Membrane in the Treatment of Myocardial Infarction', Regenerative Medicine, 14(2), pp. 113-126. |
Vancouver | Khorramirouz R, Kameli SM, Fendereski K, Daryabari SS, Kajbafzadeh AM. Evaluating the Efficacy of Tissue-Engineered Human Amniotic Membrane in the Treatment of Myocardial Infarction. Regenerative Medicine. 2019;14(2):113-126. |
BibTex | @article{ author = {Khorramirouz R and Kameli SM and Fendereski K and Daryabari SS and Kajbafzadeh AM}, title = {Evaluating the Efficacy of Tissue-Engineered Human Amniotic Membrane in the Treatment of Myocardial Infarction}, journal = {Regenerative Medicine}, volume = {14}, number = {2}, pages = {113-126}, year = {2019} } |
RIS | TY - JOUR AU - Khorramirouz R AU - Kameli SM AU - Fendereski K AU - Daryabari SS AU - Kajbafzadeh AM TI - Evaluating the Efficacy of Tissue-Engineered Human Amniotic Membrane in the Treatment of Myocardial Infarction JO - Regenerative Medicine VL - 14 IS - 2 SP - 113 EP - 126 PY - 2019 ER - |